THIOTEPA
Generic: THIOTEPA
Dr.Reddy's Laboratories Inc.Manufacturer
INTRACAVITARY, INTRAVENOUS, INTRAVESICALRoute
THIOTEPAActive Substance
2018-05-04Original Approval
THIOTEPA is FDA application ANDA210337, sponsored by DR REDDYS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
1,138 reports
2
FEBRILE NEUTROPENIA
778 reports
3
MUCOSAL INFLAMMATION
770 reports
4
PRODUCT USE IN UNAPPROVED INDICATION
592 reports
5
CYTOMEGALOVIRUS INFECTION
532 reports
6
DRUG INEFFECTIVE
532 reports
7
PYREXIA
492 reports
8
ACUTE GRAFT VERSUS HOST DISEASE
451 reports
9
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
444 reports
10
CYTOMEGALOVIRUS INFECTION REACTIVATION
424 reports